Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-26 08:52 am Unchanged | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 11,474,507 13% | 0 (Unchanged) | View |
| 2023-01-20 5:17 pm Purchase | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 11,474,507 13% | 1,767,966 (+18.21%) | View |
| 2022-03-09 5:18 pm Purchase | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 9,706,541 10.4% | 1,432,130 (+17.31%) | View |
| 2022-02-10 08:22 am Purchase | 13G | Laboratory Corporation of America Holdings LH | VANGUARD GROUP INC | 10,753,065 11.24% | 347,463 (+3.34%) | View |
| 2022-02-01 5:14 pm Purchase | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 8,274,411 8.6% | 441,846 (+5.64%) | View |
| 2021-02-10 11:14 am Sale | 13G | Laboratory Corporation of America Holdings LH | VANGUARD GROUP INC | 10,405,602 10.68% | -486,250 (-4.46%) | View |
| 2021-01-29 5:22 pm Sale | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 7,832,565 8% | -1,023,138 (-11.55%) | View |
| 2020-02-11 7:14 pm Purchase | 13G | Laboratory Corporation of America Holdings LH | VANGUARD GROUP INC | 10,891,852 11.21% | 11,109 (+0.10%) | View |
| 2020-02-05 12:16 pm Sale | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 8,855,703 9.1% | -1,173,583 (-11.70%) | View |
| 2019-04-10 1:59 pm Purchase | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 10,029,286 10.2% | 257,173 (+2.63%) | View |
| 2019-02-12 5:27 pm Sale | 13G | Laboratory Corporation of America Holdings LH | Boston Partners | 3,300,143 3.27% | -2,024,299 (-38.02%) | View |
| 2019-02-11 3:41 pm Purchase | 13G | Laboratory Corporation of America Holdings LH | VANGUARD GROUP INC | 10,880,743 10.78% | 358,347 (+3.41%) | View |
| 2019-02-06 3:05 pm Purchase | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 9,772,113 9.7% | 1,801,241 (+22.60%) | View |
| 2018-02-13 11:48 am Purchase | 13G | Laboratory Corporation of America Holdings LH | Boston Partners | 5,324,442 5.23% | 5,324,442 (New Position) | View |
| 2018-02-09 08:59 am Purchase | 13G | Laboratory Corporation of America Holdings LH | VANGUARD GROUP INC | 10,522,396 10.33% | 200,149 (+1.94%) | View |